Inhibitors of Leukotriene A4 (LTA4 ) Hydrolase as Potential Anti Inflammatory Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|3|163-179

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.3, 2001-02, pp. : 163-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel leukotriene A4 hydrolase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 1, 1999-01 ,pp. : 91-95

Informa Healthcare

Access to resources Recommend Favorite

Phospholipase A2 Inhibitors as Potential Anti-Inflammatory Agents

By  

Current Pharmaceutical Design, Vol. 11, Iss. 10, 2005-04 ,pp. : 1301-1312

Bentham Science Publishers

Access to resources Recommend Favorite

Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 3, 2004-05 ,pp. : 267-283

Bentham Science Publishers

Access to resources Recommend Favorite

Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors

By Çalışkan Burcu   Banoglu Erden  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 49-63

Informa Healthcare

Access to resources Recommend Favorite

2-Substituted-3-(4-bromo-2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents

By Goel B.   Ram T.   Tyagi R.   Bansal E.   Kumar A.   Mukherjee D.   Sinha J.N.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 3, 1999-03 ,pp. : 265-269

Elsevier

Access to resources Recommend Favorite